Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®.
Vaccines (Basel). 2023 Apr 20;11(4):874. doi: 10.3390/vaccines11040874.
Vaccines (Basel). 2023.
PMID: 37112786
Free PMC article.
Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine.
Rabdano S, Ruzanova E, Makarov D, Vertyachikh A, Teplykh V, Rudakov G, Pletyukhina I, Saveliev N, Zakharov K, Alpenidze D, Vasilyuk V, Arakelov S, Skvortsova V.
Rabdano S, et al.
Vaccines (Basel). 2024 Jan 19;12(1):100. doi: 10.3390/vaccines12010100.
Vaccines (Basel). 2024.
PMID: 38276672
Free PMC article.
Item in Clipboard
Cite
Cite